Intersect ENT, Inc.

Delisted

CIK 1271214fmd_0813H06BGBH02W08G65CM2YAXQManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2012 to Mar 31, 2022, 38 periods

Income Statement · Annual · Millions · USD
Line item	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Total revenues	6	18	39	62	79	96	108	109	81	107
Cost of revenue	4	8	10	12	13	15	23	22	30	30
Gross profit	2	10	28	49	66	81	86	87	50	77
Research and development	9	10	10	17	19	18	19	24	19	28
Selling, general and administrative	9	18	36	60	73	80	92	108	99	122
Total operating expenses	19	28	46	76	92	98	111	133	118	218
Operating income	(16)	(18)	(18)	(27)	(26)	(18)	(25)	(45)	(68)	(141)
Interest expense	0	0	0	–	–	–	0	0	3	6
Interest and investment income	0	0	0	–	–	–	–	–	–	–
Other non-operating income (expense)	–	–	(0)	0	1	1	2	2	(2)	(14)
Income before taxes	–	–	–	–	–	–	(23)	(43)	(73)	(161)
Income tax expense	0	0	0	0	0	0	0	0	(0)	(2)
Net income from continuing operations	–	–	–	–	–	–	(23)	(43)	(72)	(160)
Net income	(16)	(18)	(18)	(27)	(25)	(16)	(23)	(43)	(72)	(160)